Dermatomyositis
Not recruitingStudy on the Effects of GLPG3667 for Adults with Dermatomyositis
- Disease:Dermatomyositis
- Substances:Glpg3667 Fumarate
France- Participants:18–64 years · 65+ years
- Substances:Glpg3667 Fumarate
- Sponsor:Galapagos
Rare diseases
Investigational molecules
Locations
Back to France976 clinical trials in STRASBOURG, Alsace, France across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Advanced studies focusing on head and neck cancers, bladder cancer, and multiple myeloma. Novel therapeutic approaches combining immunotherapy with established treatments are being evaluated for improved patient outcomes.
Innovative combination therapies are being tested to enhance treatment efficacy while maintaining patient safety.
Comprehensive research into multiple sclerosis, essential tremor, and ADHD. Studies are evaluating both new and existing medications for improved symptom management and disease control.
Advanced neuroimaging techniques are being utilized to understand treatment effects on brain circuits.
Investigating new treatments for Crohn's disease, Sjögren's Syndrome, and Myasthenia Gravis. Research focuses on innovative therapeutic approaches including microbiota transplantation and targeted immunotherapies.
These trials aim to improve disease management and patient quality of life through targeted interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.